Mergers & Acquisition activity within the pharmaceutical industry ‘remains high’, report finds
Large-value deals are a new strategy for stakeholders to capitalise…
Large-value deals are a new strategy for stakeholders to capitalise on the strengths of other companies and to overcome barriers to financial success.